Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
Treatment responses of melanoma patients to MAPK pathway inhibitors are often limited. Here, the authors show that combining cardiac glycosides with MAPK inhibitors improves tumor regression by inducing intracellular acidification, mitochondrial calcium dysregulation, ATP depletion, and cell death.
Guardado en:
Autores principales: | Ugur Eskiocak, Vijayashree Ramesh, Jennifer G. Gill, Zhiyu Zhao, Stacy W. Yuan, Meng Wang, Travis Vandergriff, Mark Shackleton, Elsa Quintana, Arthur E. Frankel, Timothy M. Johnson, Ralph J. DeBerardinis, Sean J. Morrison |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af2b613ebe124fc991b554202905400b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Erratum: Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
por: Ugur Eskiocak, et al.
Publicado: (2016) -
Synergistic effect of cold atmospheric pressure plasma and free or liposomal doxorubicin on melanoma cells
por: Konstantina Pefani-Antimisiari, et al.
Publicado: (2021) -
Arginine deprivation therapy for malignant melanoma
por: Yoon JK, et al.
Publicado: (2012) -
Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma
por: Harish Potu, et al.
Publicado: (2017) -
Structural mechanism of synergistic activation of Aurora kinase B/C by phosphorylated INCENP
por: Kamal R. Abdul Azeez, et al.
Publicado: (2019)